Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: MMS stock price vs WY: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at WY's multiple
Needs WY P/E.
Implied fair value · at MMS's multiple
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Maximus, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
WEYERHAEUSER COMPANY · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Accenture plc
MMS vs ACN
INTERNATIONAL BUSINESS MACHINES CORP
MMS vs IBM
CACI INTERNATIONAL INC /DE/
MMS vs CACI
ROLLINS INC
MMS vs ROL
CINTAS CORP
MMS vs CTAS
IRON MOUNTAIN INC
MMS vs IRM
RAYONIER INC
MMS vs RYN
POTLATCHDELTIC CORP
MMS vs PCH
INTERNATIONAL PAPER CO /NEW/
MMS vs IP
UFP INDUSTRIES INC
MMS vs UFPI
VORNADO REALTY TRUST
MMS vs VNO
COSTAR GROUP, INC.
MMS vs CSGP
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe MMS can sustain its stronger growth, ROIC, and valuation discount versus WY, then MMS looks more attractive to own because it offers better fundamentals at far lower multiples; however, the reported implied-price output should be validated first because it appears inconsistent with WY range and current price.
MMS trades at a sharp discount to WY on both earnings and revenue-based multiples, which is directionally supported by MMS’s stronger fundamentals. However, the valuation output is internally inconsistent because the stated implied price of $306.48 sits far above WY implied range of $259.78-$337.75 and well above the current price of $60.25, so the comparison should be treated cautiously.
Supporting Metrics
